IP Library Granted Patent US 7,214,206
Granted Patent B2
US 7,214,206 · App. 10/406,397 · Granted May 8, 2007

Implanting device and method of using same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,214,206
App. No.
10/406,397
Granted
May 8, 2007
Kind
B2
Abstract

A device for inserting implantable objects beneath the skin of a patient includes a handle for grasping the device and a base connected to the handle. The base comprises a post, a cannula, and a flexible actuator positioned in an angled track. The cannula is positioned coaxially around and is longitudinally slidable over the post from an extended position, where an implantable object is retained in the cannula, to a retracted position, where the implantable object is released from the cannula. A flexible actuator positioned on an angled track in the base is slidably engaged with a boss on the cannula and is used to move the cannula from an extended position to a retracted position to release the implantable object from the cannula; the actuator flexes between a locked and an unlocked position. The angled track provides for control of the release of the implantable object.

Claims (24)

1. A device for implanting at least one object beneath the skin of a patient comprising:

a handle for grasping the device during insertion of an object, the handle having a distal end, a proximal end, and an angled track formed on the handle;

a base connected to the handle, the base comprising:

a post longitudinally fixed to the handle, the post extending from the distal end of the handle;

a hollow cannula positioned coaxially around and longitudinally slidable over the post from an extended position, in which at least one object is retained in the cannula, to a retracted position, in which at least one object is released from the cannula;

and a flexible actuator slidably engaged to the cannula to move the cannula from the extended position to the retracted position to release the object from the cannula, wherein the actuator flexes between a locked and an unlocked position, wherein the flexible actuator comprises a button, a boss channel, at least two guide posts, a guide, and a tab extending upwardly and non-parallel from the guide posts attached to the cannula, wherein the boss channel engages the guide posts and permits a pulling or pushing force to be exerted on the cannula, for extension or retraction, as the flexible actuator tab is moved by moving the button along the angled track.

2. The device of claim 1 wherein pressing the flexible actuator in the distal position of the angled track engages a locking portion of the actuator to prevent retraction of the cannula.

3. The device of claim 2 wherein the flexible actuator is released from the locked position by pressing the actuator.

4. The device of claim 1 further comprising one or more implantable objects.

5. The device of claim 1 , wherein the implantable objects comprise one or more of either therapeutics, pharmaceuticals, or microencapsulated sensors.

6. The device of claim 1 further comprising a cartridge removably mounted and parallel to a central bore of said cannula and a means for moving objects into the cannula for delivery upon retraction of said cannula.

7. The device of claim 1 wherein the angled track is formed from two opposing recessed track walls angled with respect to the post.

8. The device of claim 1 wherein the angled track is either linear or curvilinear.

9. The device of claim 1 wherein the angled track has a stop at the distal portion that permits securing of the actuator and locks the cannula in a loaded position.

10. The device of claim 1 wherein the base includes a bottom surface that is substantially planar and parallel to the cannula.

11. The device of claim 1 , wherein the cannula includes a tip at the distal end that is formed from at least one beveled angle of between 30 and 45 degrees.

12. The device of claim 1 wherein the cannula includes a tip at the distal end that is formed at a sharp point of 27 degrees.

13. The device of claim 1 , wherein the cannula includes a depth indicating marker.

14. A system for implanting an object beneath the skin of a patient, comprising:

means for creating an incision into the skin of the patient;

means for maintaining a sterile environment;

means for placing the implantable object beneath the skin of the patient, comprising an angled means for insertion beneath the skin and a means for withdrawing the angled means for insertion while leaving the implantable object beneath the skin;

angled means for manually controlling the insertion of the implantable object to prevent unnecessary damage to patient tissue from force; and

a flexible actuator means for controlling the depth of insertion.

Assignments (11)
SECURITY INTEREST Recorded Aug 26, 2024
From: ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068401/0578 →
SECURITY INTEREST Recorded Aug 26, 2024
From: ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068401/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067800/0107 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: ENDO USA, INC.
Reel/Frame 067198/0892 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 032380/0226 →